Dynavax Technologies Corporation (NASDAQ:DVAX) surged 8% Thursday following the announcement of encouraging topline data from its Phase 1/2 trial of Z-1018, the company’s experimental shingles vaccine ...

GSK plc has announced the acquisition of American Depositary Shares (ADSs) by two of its executives, Dr. Hal Barron and James Ford, through reinvestment of dividends in their respective savings plans.

In conclusion, GlaxoSmithKline's shares showed significant gains today, reflecting positive market sentiment and strong ...

With the stock currently priced at Rs 2,724.90, GlaxoSmithKline Pharmaceuticals shows significant activity in today's session ...

GlaxoSmithKline's chief executive officer said in an email to the company’s employees that Slaoui’s name would be removed from its research and development facility in Rockville, Md.

Sanofi, GlaxoSmithKline pledge 200M COVID-19 vaccines for global use By Noah Manskar Published Oct. 28, 2020, 11:41 a.m. ET ...

TAMPA — Blair Hamrick left for Colorado in 1993, an ambitious University of Tampa graduate headed for a six-figure job as a pharmaceutical sales rep.

GlaxoSmithKline today participated in a U.S. Food and Drug Administration (FDA) advisory committee meeting convened to discuss recent findings of porcine circovirus (PCV) in rotavirus vaccines.

GlaxoSmithKline is accused in a lawsuit of using threats to block generic competition to its $2-billion-a-year antibiotic Augmentin after a U.S. judge eliminated the drug's patent protection.

T he French drug giant Sanofi said Tuesday that it plans to use technology from GlaxoSmithKline to accelerate the development of its experimental vaccine against the novel coronavirus, SARS-CoV-2.

On February 4, 2015, GlaxoSmithKline PLC (NYSE: GSK, $46.39, Market Capitalization: $113 billion) declared 4Q14 results and updated on the potential IPO of its HIV unit, ViiV Healthcare ...